e-learning
resources
ERJ
2004
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
G-CSF enables completion of tuberculosis therapy associated with iatrogenic neutropenia
Cormican L.J., Schey S., Milburn H.J.
Source:
Eur Respir J 2004; 23: 649-650
Journal Issue:
April
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Cormican L.J., Schey S., Milburn H.J.. G-CSF enables completion of tuberculosis therapy associated with iatrogenic neutropenia. Eur Respir J 2004; 23: 649-650
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis
Source: ERJ Open Res, 7 (3) 00836-2020; 10.1183/23120541.00836-2020
Year: 2021
Isoniazid protection and risk of tuberculosis in patients who used anti tumor necrosis factor-alpha treatment
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
Re-activation of bovine tuberculosis in a patient treated with infliximab
Source: Eur Respir J 2008; 32: 229-231
Year: 2008
Screening and monitoring of tuberculosis in patients on tumor necrosis factor antagonist therapy
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
Source: Eur Respir J 2010; 36: 1185-1206
Year: 2010
Febrile episodes without leukopenia are more important for survival than febrile leukopenia in lung cancer patients receiving chemotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 76s
Year: 2005
Glucocorticosteroid therapy as predisposing factor for pulmonary sarcoidosis relapse
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018
Pulmonary infections in patients receiving treatment of tumor necrosis factor alpha antagonists
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Granulocyte-macrophage colony stimulating factor inhalation therapy as a treatment for pulmonary alveolar proteinosis
Source: Eur Respir J 2003; 22: Suppl. 45, 377s
Year: 2003
Mycobacterial diseases developed during anti-tumour necrosis factor alpha therapy
Source: Eur Respir J 2014; 44: 1289-1295
Year: 2014
A case with rifampicin induced severe trombocytopenia during tuberculosis treatment
Source: Annual Congress 2007 - Difficult tuberculosis cases I
Year: 2007
Efficacy of aerosolized granulocyte-macrophage colony stimulating factor (GM-CSF) in a Japanese female patient with pulmonary alveolar proteinosis (PAP)
Source: Eur Respir J 2001; 18: Suppl. 33, 221s
Year: 2001
Granulocyte colony-stimulating factor enhances the anticancer effects of cisplatin against lung cancer by promoting angiogenesis
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008
Screening for latent tuberculosis before tumour necrosis factor antagonist therapy
Source: Eur Respir J 2015; 45: 1510-1512
Year: 2015
Screening for latent tuberculosis before tumour necrosis factor antagonist therapy
Source: Eur Respir J 2015; 45: 1512-1513
Year: 2015
Inhaled granulocyte–macrophage colony-stimulating factor for
Mycobacterium abscessus
in cystic fibrosis
Source: Eur Respir J, 51 (4) 1702127; 10.1183/13993003.02127-2017
Year: 2018
The risk of tuberculosis related to tumour necrosis factor antagonist therapies
Source: Annual Congress 2011 - TBNET: tuberculosis research in Europe
Year: 2011
Antibiotic prophylaxis in chemotherapy-induced neutropenia in lung cancer patients
Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Year: 2011
Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity
Source: Eur Respir J 2003; 21: 842-847
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept